We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

BioTek Announces New Applications and Business Development Manager in Canada

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute
"Dr. Amirmansour has a unique set of skills, creating cutting-edge business development programs, with an extensive background in life science and drug discovery applications," notes Gary Barush, BioTek's Director of Marketing & Sales. "Additionally, his strong academic background will resonate with our research-based microplate technologies."

Prior to joining BioTek, Dr. Amirmansour held various positions at PerkinElmer, Inc., most recently as Product Line Leader and Sr. Technology Specialist. Following the receipt of his doctorate in clinical pharmacology, Dr. Amirmansour worked as a post-doctoral research fellow at The William Harvey Research Institute, National Heart & Lung Institute and Harefield Heart Science Centre under the supervision of Nobel Laureates, Professors Sir John Vane and Sir Magdy Yacoub.
We congratulate Dr. Amirmansour as he assumes his new responsibilities.

BioTek Instruments, Inc., headquartered in Winooski, VT, USA, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. BioTek instrumentation is used to aid in the advancement of life science research, facilitate the drug discovery process and to enable cost-effective quantification of disease relevant molecules in the clinic.